𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radical radiotherapy for early nonsmall cell lung cancer

✍ Scribed by Peter H. Graham; Val J. Gebski; M. Stat; Allan O. Langlands

Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
682 KB
Volume
31
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Stereotactic single-dose radiotherapy (r
Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC)
✍ Holger Hof; Marc Muenter; Dieter Oetzel; Angelika Hoess; Juergen Debus; Klaus He πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 347 KB

## Abstract ## BACKGROUND. The clinical results after stereotactic single‐dose radiotherapy of nonsmall‐cell lung cancer (NSCLC) stages I and II were evaluated. ## METHODS. Forty‐two patients with biopsy‐proven NSCLC received stereotactic radiotherapy. Patients were treated in a stereotactic bod

Circulating micro-RNA expression profile
Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer
✍ Niels H.H. Heegaard; Aaron J. Schetter; Judith A. Welsh; Mitsuhiro Yoneda; Elise πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 341 KB πŸ‘ 2 views

## Abstract Circulating micro‐RNA (miR) profiles have been proposed as promising diagnostic and prognostic biomarkers for cancer, including lung cancer. We have developed methods to accurately and reproducibly measure micro‐RNA levels in serum and plasma. Here, we study paired serum and plasma samp

Review: Perioperative therapy for locore
Review: Perioperative therapy for locoregional nonsmall-cell lung cancer
✍ Takita, Hiroshi πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 929 KB

Surgical therapy remains the treatment of choice for resectable nonsmallcell lung cancer (NSCLC). However, the 5-year survival results of surgical therapy is 40-70%, which is far from acceptable. In this report, past results of perioperative therapies were reviewed to identify the future direction o